IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FANZANI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.893
EU - Europa 3.432
AS - Asia 2.906
SA - Sud America 438
AF - Africa 44
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.794
PL - Polonia 1.202
CN - Cina 1.026
SG - Singapore 969
IT - Italia 532
UA - Ucraina 514
BR - Brasile 372
DE - Germania 372
HK - Hong Kong 316
GB - Regno Unito 219
FI - Finlandia 206
VN - Vietnam 142
IN - India 119
TR - Turchia 106
RU - Federazione Russa 99
IE - Irlanda 89
CA - Canada 53
FR - Francia 46
JP - Giappone 42
BD - Bangladesh 41
MX - Messico 29
CZ - Repubblica Ceca 27
AR - Argentina 25
ID - Indonesia 24
ES - Italia 22
IQ - Iraq 21
SE - Svezia 20
BE - Belgio 18
NL - Olanda 18
SA - Arabia Saudita 16
ZA - Sudafrica 16
AT - Austria 13
AU - Australia 13
UZ - Uzbekistan 10
EC - Ecuador 9
VE - Venezuela 9
IR - Iran 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
KE - Kenya 7
KR - Corea 7
CH - Svizzera 6
EG - Egitto 6
KZ - Kazakistan 6
MA - Marocco 5
PA - Panama 5
PY - Paraguay 5
AL - Albania 4
EU - Europa 4
KG - Kirghizistan 4
LV - Lettonia 4
PE - Perù 4
TT - Trinidad e Tobago 4
CL - Cile 3
DK - Danimarca 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
KW - Kuwait 2
MU - Mauritius 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TN - Tunisia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
Totale 12.726
Salva come PNG Salva come JPEG
Città #
Warsaw 1.200
Fairfield 620
Ashburn 538
Woodbridge 508
Singapore 432
Jacksonville 369
Hong Kong 313
Houston 306
Cambridge 243
Seattle 235
Beijing 231
Brescia 229
Chandler 218
Wilmington 218
Ann Arbor 193
New York 181
Princeton 157
Los Angeles 151
Nanjing 132
Chicago 127
Helsinki 96
Lancaster 90
Dublin 89
The Dalles 87
Istanbul 84
Munich 67
Dearborn 62
Buffalo 60
Jinan 56
Salt Lake City 54
Des Moines 53
Shenyang 51
Nanchang 48
Dallas 47
Milan 44
Hebei 38
Ho Chi Minh City 38
San Francisco 38
Shanghai 38
Redondo Beach 36
Moscow 35
Tianjin 35
Dong Ket 34
Changsha 33
Elk Grove Village 31
Turku 31
Verona 30
Hanoi 27
San Diego 27
Brooklyn 25
Jakarta 24
São Paulo 24
London 23
Tampa 22
Boston 21
Denver 21
Ningbo 20
Santa Clara 20
Hangzhou 18
Phoenix 18
Taizhou 18
Brussels 17
Rome 17
Stockholm 16
Olomouc 15
Urbino 15
Zhengzhou 15
Atlanta 14
Kunming 14
Nuremberg 14
Salerno 14
Tokyo 14
Toronto 14
Lappeenranta 13
Manchester 13
New Delhi 13
Poplar 13
Boardman 12
Dhaka 12
Johannesburg 12
Montreal 12
Ottawa 12
San Mateo 12
Taiyuan 12
Brno 11
Charlotte 11
Frankfurt am Main 11
Guangzhou 11
Mexico City 11
Sterling 11
Baghdad 10
Norwalk 10
Orem 10
Washington 10
Ankara 9
Bergamo 9
Miami 9
Rio de Janeiro 9
Tashkent 9
Belo Horizonte 8
Totale 8.788
Salva come PNG Salva come JPEG
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 571
Inhibition of glutathione peroxidase 4 primes mouse C2C12 myoblasts and rhabdomyosarcoma cell lines to ferroptosis 318
Characterization of the AP-1 μ1A and μ1B adaptins in zebrafish (Danio rerio) 288
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma. 266
Caveolin-3, MURC and Trim72 predict myogenic differentiation in the human embryonal rhabdomyosarcoma RD cell line 263
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 250
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 243
Intake of Special Amino Acids Mixture Leads to Blunted Murine Colon Cancer Growth In Vitro and In Vivo 232
Melatonin action in tumor skeletal muscle cells: an ultrastructural study 227
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 213
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 203
Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways 192
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 185
Melatonin effects in normal and tumoral skeletal muscle cells: a preliminary study 183
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 181
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 179
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 177
Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes 176
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems 172
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 172
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 171
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 165
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy. 158
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 155
Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. 154
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines 154
Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts 152
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 152
Rhabdomyosarcomas: an overview on the experimental animal models. 152
Implications for the mammalian sialidases in the physiopathology of skeletal muscle 151
Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations 150
Caveolin-1-overexpression induces deep plasma membrane rearrangement and secretion of extracellular vesicles in a model of rhabdomyosarcoma 148
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. 146
Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation 146
Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. 141
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 141
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 141
Autophagic degradation contributes to muscle wasting in cancer cachexia 141
Biochemical characterization of Neu2, a novel human cytosolic sialidase 139
Uncovering metabolism in rhabdomyosarcoma 139
The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. 133
Caveolins in rhabdomyosarcoma 133
Focus on the role of Caveolin and Cavin protein families in liposarcoma 132
Cavin-2 is a specific marker for detection of well-differentiated liposarcoma. 131
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 131
Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines 131
Molecular and cellular mechanisms of skeletal muscle atrophy: an update 130
Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. 128
Design and optimization of lentiviral vectors for transfer of galc expression in twitcher brain 127
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 124
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 124
Validation of PTRF/cavin-1 expression and plasma membrane association with caveolin-1 in human cell lines and mouse primary tumor cultures of rhabdomyosarcoma 123
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas 122
AUTOPHAGIC DEGRADATION CONTRIBUTES TO MUSCLE WASTING IN CANCER CACHEXIA 121
Intracellular vesicular traffic:cloning, expression and antisense inhibition of AP1m1 subunit ortholog in zebrafish 116
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. 116
Guidelines for the use and interpretation of assays for monitoring autophagy 113
IGF-I SIGNALING REGULATES CYTOSOLIC SIALIDASE NEU2 DURING MYOBLAST HYPERTROPHY. 111
CAVEOLINS AND CAVINS IN MUSCLE-DERIVED TUMOURS 111
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 111
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 109
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 106
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 104
Involvment of sialidases in differentation of PC12 101
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 100
The cytosolic sialidase Neu2 is substrate of degradation by autophagy during myoblast atrophy 98
Caveolin-1-overexpression induces extracellular vesicle secretion in a model of rhabdomyosarcoma 98
The expression of Caveolin-3 and its related Limb Girdle Muscular Dystrophy 1-c mutants in myoblasts: physiological and pathological aspects 96
IGF-I INDUCED HYPERTROPHY OF MYOBLASTS INCREASES CYTOSOLIC SIALIDASE NEU2 THROUGH PI-3 KINASE/AKT/mTOR PATHWAY. 95
DORSOMORPHIN, A SELECTIVE INHIBITOR OF SMAD1/5/8 PHOSPHORYLATION, IS A POTENT ENHANCER OF MYOBLAST DIFFERENTIATION 94
Intracellular vesicular traffic: identification and expression of zebrafihs APM1 during zebrafish development 93
The chemotherapic compound cisplatin causes myotube atrophy by increment of proteasoma activation. 91
L6E9 Myoblasts Are Deficient of Myostatin and Additional TGF-βMembers Are Candidates to Developmentally Control Their FiberFormation 91
Developmental expression of the sialidase Neu2 ortholog gene in zebrafish and characterization of the knock-down model. 89
INDUCTION OF MYOBLAST DIFFERENTIATION BY THE CYTOSOLIC SIALIDASE NEU2 OVEREXPRESSION 89
FUNCTIONAL ANTAGONISM BETWEEN P38 AND MYOSTATIN PATHWAYS IN RHABDOMYOSARCOMA CELLS 87
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and ERK signalling pathways 87
Generation and characterization of chemoresistant embryonal rhabdomyosarcoma RD line 82
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 81
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 78
THE MISSENSE CAV-3/P104L MUTATION, INVOLVED IN THE ONSET OF LIMB GIRDLE MUSCULAR DYSTROPHY 1-C, CONFERS AN IMMATURE SIGNATURE TO C2C12 MYOBLASTS 75
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 74
Expression of a myrystoilated Akt1 isoform in rhabdomyosarcoma cells promotes chemo and radioresistance, but confers marked susceptibility to metabolic drug inhibitors 65
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 65
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 63
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 60
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 57
Essential Amino Acids-Rich Diet Decreased Adipose Tissue Storage in Adult Mice: A Preliminary Histopathological Study 55
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 48
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 47
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo 45
MS-275 (Entinostat) Promotes Radio-sensitivity in PAX3-FOXO1 Rhabdomyosarcoma cells 44
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma 42
Radioresistance in rhabdomyosarcomas: Much more than a question of dose 41
Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme 40
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204 40
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 37
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 36
Nanostructured Hybrid Polymer-Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy 34
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 34
Totale 13.026
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021913 0 0 0 0 0 137 73 169 174 127 164 69
2021/2022697 40 128 20 14 6 22 48 37 27 97 95 163
2022/2023693 87 24 31 41 60 165 5 63 112 10 39 56
2023/2024817 55 13 108 41 42 159 26 43 177 21 15 117
2024/20252.371 39 10 32 254 197 138 144 64 251 110 844 288
2025/20262.344 413 474 232 514 504 207 0 0 0 0 0 0
Totale 13.046